FindTrial
Sign In

TO STUDY THE EFFECT OF KANTAKARYAVALEHYA (a drug used in treating Asthma, Bronchitis, Cough) ON IgE (an immunoglobulin involved in Asthma in Children, Allergies, etc) LEVELS IN CHILDHOOD ASTHMA

TO STUDY THE EFFECT OF KANTAKARYAVALEHYA ON IgE LEVELS IN CHILDHOOD ASTHMA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/10/006323
Enrollment
30
Registered
2015-10-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- CHILDHOOD ASTHMA

Interventions

Intervention1: KANTAKARYAVALEHYA: The drug Kantakaryavalehya is mentioned under Kasa rogadhikara of Bhaishajya Ratnavali which contains drugs like Kantakari, Chavya, Pippali, Maricha, Musta, Chitraka,

Sponsors

RGUHS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients in the age group of 5 to 15 years. 2.Atopics 3.Increased IgE levels 4.Intermittent, Mild Persistent and Moderate Persistent Asthma.

Exclusion criteria

Exclusion criteria: 1.Patients with Cardiovascular, Renal and other systemic disorders. 2.Patients with other chronic and infective disorders of respiratory system. 3.Primary Complex. 4.Foreign body aspiration. 5.Acute Severe Asthma. 6.Severe Persistent Asthma

Design outcomes

Primary

MeasureTime frame
THE EFFICACY OF KANTAKARYAVALEHYA IS ALREADY PROVED IN THE PREVIOUS STUDY DONE BY THE PRINCIPAL INVESTIGATOR. THIS STUDY INTENDS TO LOOK INTO THE EFFECT OF THE SAME DRUG ON IgE LEVELS IN CASES OF CHILDHOOD ASTHMATimepoint: THE EFFICACY OF KANTAKARYAVALEHYA IS ALREADY PROVED IN THE PREVIOUS STUDY DONE BY THE PRINCIPAL INVESTIGATOR. THIS STUDY INTENDS TO LOOK INTO THE EFFECT OF THE SAME DRUG ON IgE LEVELS IN CASES OF CHILDHOOD ASTHMA. Will be assessed at the end of the study period of three months.—

Secondary

MeasureTime frame
1. BEING A COST EFFECTIVE TREATMENT MODALITY 2. TREATMENT MODALITY WITH NIL OR VERY MINIMAL SIDE EFFECTS 3. OTHER ADD ON BENEFITS LIKE INCREASE IN APPETITE.Timepoint: 2 YEARS—

Countries

India

Contacts

Public ContactDr MADHUSUDAN B G

JSS AYURVEDA MEDICAL COLLEGE, MYSURU

drmadhusudanbg@gmail.com9986284748

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026